Product Type: | Alpaca monoclonal VHH domain of alpaca IgG2b/2c fused to Human IgG1 Fc(mutation), primary antibodies |
---|---|
Species reactivity: | Human |
Applications: | ELISA, FC |
Clonality: | Monoclonal |
Form: | Liquid |
Storage condition: | Store at –20 ℃, (Avoid freeze / thaw cycles), Stable for 12 months at -20℃ |
Storage buffer: | Liquid, 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% Glycerol |
Concentration: | 1ug/ul |
Purification: | Immunogen affinity purified. |
Isotype: | VHH domain of alpaca IgG2b/2c fused to Human IgG1 Fc(mutation) |
Immunogen: | Recombinant human IL-6R |
Subcellular location: | Cell membrane, Secreted |
Recommended Dilutions:
ELISA FC |
1:4,000-1:10,000 1:200-1:1,000 |
Uniprot #: | SwissProt: P08887 Human |
Alternative names: | CD 126 CD126 CD126 antigen gp80 IL 6R 1 IL 6R alpha IL 6R IL-6 receptor alpha chain IL-6 receptor subunit alpha IL-6R 1 IL-6R subunit alpha IL-6R-alpha IL-6RA IL6Q Il6r IL6RA IL6RA_HUMAN IL6RQ Interleukin 6 receptor interleukin 6 receptor alpha Interleukin-6 receptor subunit alpha Membrane glycoprotein 80 MGC30256 |
Fig1:
Advantages of using an Alpaca Recombinant Secondary 1. Smaller size Nanobodies are 1/10 the size of a traditional antibody (~15 kDa unconjugated). This means that the nanobody can penetrate tissue faster and deeper than other antibodies. 2. Easier to use Due to their simple structure, nanobodies also have the advantage of increased stability and ease of use. 3. Easier production When compared to a more traditional antibody, nanobodies are easier to develop and produce in the lab than monoclonal or polyclonal antibodies. 4. More consistent Since nanobodies are recombinantly produced from clonal DNA, you are guaranteed the same product every time. Comparatively, polyclonal antibodies are produced in live animals and have a very low lot-to-lot consistency while monoclonal antibodies can suffer from drift. 5. Higher Affinity Nanobodies benefit from consistently high binding affinity values. |